Skip to main content

Daniel Farkas

Celmatix has appointed Daniel Farkas chief clinical laboratory officer for its new laboratory in Brooklyn, New York. He will be using his experience to lead the development of the new laboratory, which will conduct sequencing for the firm's genetic panel for fertility disorders.

Farkas has decades of experience in molecular diagnostics. He most recently worked as the lead laboratory director at Sequenom's clinical reference laboratories in San Diego; Grand Rapids, Michigan; and Morrisville, North Carolina. He has also served as president of the Association for Molecular Pathology; was the first professional to be certified in molecular diagnostics by the American Board of Bioanalysis; and has helped establish best practices in molecular pathology through his tenure on the College of American Pathologists' Molecular Pathology Resource Committee. 

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.